High Purity New England

High Purity New England (HPNE) is a long-established, private company that operates as a critical supplier and solutions provider within the bioprocessing and drug delivery supply chain. It functions primarily as a value-added distributor and manufacturer of single-use and multi-use equipment for upstream, downstream, lab, and fill-finish applications. The company was acquired by Getinge, a global medical technology company, in October 2023, providing significant financial backing and global reach. HPNE's business model is service-oriented, generating revenue through product sales, distribution, and technical support, positioning it as an enabler for biopharma production rather than a drug developer.

Integrated supplier, distributor, and manufacturer of bioprocessing equipment and single-use assemblies. Provides custom engineering, systems integration, and maintenance services for the biopharma manufacturing workflow.

HPNE competes in the fragmented bioprocessing equipment market against giants like Danaher (Cytiva), Merck Millipore, and Thermo Fisher Scientific, as well as numerous specialized distributors and single-use assembly fabricators. Its differentiation lies in its broad multi-brand distribution, custom engineering capability, and focused service support.